[Dukoral, oral cholera vaccine]. - Suppr | 超能文献

[Dukoral, oral cholera vaccine].

作者信息

Ragot C, Garnotel E, Vedy S, Morillon M

机构信息

Service de biochimie toxicologie, de l'Hôpital d'instruction des armées Laveran, Marseille, France.

出版信息

Med Trop (Mars). 2006 Jun;66(3):237-9.

Abstract

摘要

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

文档翻译

学术文献翻译模型，支持多种主流文档格式。

相似文献

1

[Dukoral, oral cholera vaccine].

Med Trop (Mars). 2006 Jun;66(3):237-9.

2

Safety and immunogenicity study of a killed bivalent (O1 and O139) whole-cell oral cholera vaccine Shanchol, in Bangladeshi adults and children as young as 1 year of age.沙克霍（Shanchol）二价（O1 和 O139）全细胞口服霍乱疫苗在孟加拉国成年人和 1 岁以下儿童中的安全性和免疫原性研究。

Vaccine. 2011 Oct 26;29(46):8285-92. doi: 10.1016/j.vaccine.2011.08.108. Epub 2011 Sep 9.

3

[Cholera vaccine].[霍乱疫苗]

Nihon Rinsho. 2005 May;63 Suppl 5:625-30.

4

Questionable merits of the field trial of an oral killed whole cell cholera vaccine in Vietnam during 1998-2003.1998 - 2003年期间越南口服灭活全细胞霍乱疫苗现场试验的可疑价值。

Vaccine. 2007 Feb 9;25(8):1353-4. doi: 10.1016/j.vaccine.2006.09.057. Epub 2006 Oct 4.

5

[Travellers' compliance with the use of an oral cholera vaccine].[旅行者对口服霍乱疫苗的使用依从性]

Ig Sanita Pubbl. 2010 Jul-Aug;66(4):409-18.

6

Robust gut associated vaccine-specific antibody-secreting cell responses are detected at the mucosal surface of Bangladeshi subjects after immunization with an oral killed bivalent V. cholerae O1/O139 whole cell cholera vaccine: comparison with other mucosal and systemic responses.在孟加拉国受试者口服灭活二价霍乱弧菌O1/O139全细胞霍乱疫苗免疫后，在其黏膜表面检测到强大的肠道相关疫苗特异性抗体分泌细胞反应：与其他黏膜和全身反应的比较。

Vaccine. 2009 Feb 25;27(9):1386-92. doi: 10.1016/j.vaccine.2008.12.041. Epub 2009 Jan 13.

7

Safety and immunogenicity of a reformulated Vietnamese bivalent killed, whole-cell, oral cholera vaccine in adults.一种重新配制的越南双价灭活全细胞口服霍乱疫苗在成人中的安全性和免疫原性。

Vaccine. 2007 Jan 22;25(6):1149-55. doi: 10.1016/j.vaccine.2006.09.049. Epub 2006 Sep 29.

8

Development of Peru-15 (CholeraGarde), a live-attenuated oral cholera vaccine: 1991-2009.秘鲁-15（霍乱疫苗）的研发：1991-2009 年，一种减毒口服霍乱疫苗。

Expert Rev Vaccines. 2009 Dec;8(12):1643-52. doi: 10.1586/erv.09.137.

9

Randomized placebo controlled human volunteer trial of a live oral cholera vaccine VA1.3 for safety and immune response.口服霍乱活疫苗VA1.3安全性及免疫反应的随机安慰剂对照人体志愿者试验

Vaccine. 2009 Jul 30;27(35):4850-6. doi: 10.1016/j.vaccine.2009.05.065. Epub 2009 Jun 10.

10

A randomized, non-inferiority trial comparing two bivalent killed, whole cell, oral cholera vaccines (Euvichol vs Shanchol) in the Philippines.在菲律宾进行的一项随机、非劣效性试验，比较两种二价灭活全细胞口服霍乱疫苗（Euvichol与Shanchol）。

Vaccine. 2015 Nov 17;33(46):6360-5. doi: 10.1016/j.vaccine.2015.08.075. Epub 2015 Sep 5.

引用本文的文献

1

Properties and applications of nanoparticle/microparticle conveyors with adjuvant characteristics suitable for oral vaccination.具有佐剂特性的纳米颗粒/微颗粒输送载体的性质和应用，适用于口服疫苗接种。

Int J Nanomedicine. 2018 May 21;13:2973-2987. doi: 10.2147/IJN.S154743. eCollection 2018.

2

Preformulation studies with the Escherichia coli double mutant heat-labile toxin adjuvant for use in an oral vaccine.用于口服疫苗的大肠杆菌双突变体不耐热毒素佐剂的处方前研究。

J Immunol Methods. 2017 Dec;451:83-89. doi: 10.1016/j.jim.2017.09.003. Epub 2017 Sep 20.